The International Eosinophil Society (IES) is a global community of scientists and clinicians united in advancing understanding and treatment of eosinophil-related diseases, leading to improved patient outcomes and enhanced quality of life.
News
2024 IES Lifetime Achievement Award Webinar:
Celebrating Gerald J. Gleich's Legacy in Eosinophil Research
Speakers
Steven Ackerman, PhD
Allison Fryer, PhD
Gerald J. Gleich, MD
Hirohito Kita, MD
Biannual Depemokimab for Severe Eosinophilic Asthma
Article: Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
Reviewed by Santi Nolasco, University of Catania, Italy
IES Accepted as WAO Member Society
We are proud to announce that the International Eosinophil Society has officially been accepted as a World Allergy Organization (WAO) Affiliate Member Society. We are now enlisted as one of 115 elite member societies of an alliance of allergy societies to advance excellence in clinical care, research, education and training. Learn more about WAO here.
Explore the latest published research from the 2023 IES Congress, now available in the Journal of Leukocyte Biology. A comprehensive issue with these and more contributions is coming soon. Stay tuned for updates!
Free Membership for Early Career Individuals
Enhance your career with Early Career Membership! Ideal for pre-doctoral and post-doctoral fellows, clinical fellows, and residents, this membership provides free benefits to help you grow.
13th Biennial Congress
7-11 July 2025
Montpellier, France
The 13th Biennial Congress of the International Eosinophil Society (IES) in 2025 will unite global experts to advance eosinophil research through cutting-edge sessions and collaborative discussions. Join us as we explore new frontiers in the field and strengthen global connections within the eosinophil research community.
